Literature DB >> 7933822

Renal ammonia in autosomal dominant polycystic kidney disease.

V E Torres1, D S Keith, K P Offord, S P Kon, D M Wilson.   

Abstract

Recent studies have suggested that defective medullary trapping of ammonia underlies the acidosis associated with renal failure and sets in motion maladaptive compensatory mechanisms that contribute to the progression of renal disease. Since a renal concentrating defect is an early functional abnormality in autosomal dominant polycystic kidney disease (ADPKD), defective medullary trapping and urinary excretion of ammonia may also occur early and have important pathophysiological consequences. The urinary pH and excretions of ammonia, titratable acid, and bicarbonate, were measured during a 24-hour baseline period and following the administration of ammonium chloride (100 mg/kg body wt) in ADPKD patients with normal glomerular filtration rate and in age- and gender-matched healthy control subjects. The distal nephron hydrogen ion secretory capacity was assessed during a bicarbonate infusion. Ammonia, sodium, pH, C3dg, and C5b-9 were measured in cyst fluid samples. The excretion rates of ammonia during the 24-hour baseline period and following the administration of ammonium chloride were significantly lower, and the relationship of ammonia excretion to urinary pH was significantly shifted downward in ADPKD. No difference in the increment of urinary pCO2 (delta pCO2) or the peripheral blood-urine pCO2 gradient (U-B pCO2) between ADPKD patients and control subjects was detected during a sodium bicarbonate infusion. Calculated concentrations of free-base ammonia in cyst fluid samples exceeded those calculated from reported concentrations of ammonia in renal venous blood of normal subjects. C3dg and C5b-9 were detected in some cyst fluids. The urinary excretion of ammonia is reduced in ADPKD patients with normal glomerular filtration rate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7933822     DOI: 10.1038/ki.1994.227

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

1.  Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan.

Authors:  Matteo Bargagli; Nasser A Dhayat; Manuel Anderegg; Mariam Semmo; Uyen Huynh-Do; Bruno Vogt; Pietro Manuel Ferraro; Daniel G Fuster
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-11       Impact factor: 8.237

Review 2.  Lithiasis in cystic kidney disease and malformations of the urinary tract.

Authors:  G Gambaro; A Fabris; D Puliatta; A Lupo
Journal:  Urol Res       Date:  2006-01-14

Review 3.  Polycystic kidney disease--a truly pediatric problem.

Authors:  M R Ogborn
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

Review 4.  Insights into cellular and molecular basis for urinary tract infection in autosomal-dominant polycystic kidney disease.

Authors:  Chao Gao; Long Zhang; Ye Zhang; Darren P Wallace; Reynold I Lopez-Soler; Paul J Higgins; Wenzheng Zhang
Journal:  Am J Physiol Renal Physiol       Date:  2017-08-09

5.  Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease.

Authors:  Renato Ribeiro Nogueira Ferraz; Jonathan Mackowiak Fonseca; Gregory George Germino; Luiz Fernando Onuchic; Ita Pfeferman Heilberg
Journal:  Urolithiasis       Date:  2014-05-10       Impact factor: 3.436

6.  Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients.

Authors:  José L Nishiura; Rodrigo F C A Neves; Samara R M Eloi; Susan M L F Cintra; Sergio A Ajzen; Ita P Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

Review 7.  Nutritional therapy in autosomal dominant polycystic kidney disease.

Authors:  Biagio R Di Iorio; Adamasco Cupisti; Claudia D'Alessandro; Antonio Bellasi; Vincenzo Barbera; Luca Di Lullo
Journal:  J Nephrol       Date:  2018-01-17       Impact factor: 3.902

8.  Cystinuria in a patient with polycystic kidney disease.

Authors:  Kate Love; Fred E Yeo
Journal:  NDT Plus       Date:  2008-11-11

9.  A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.

Authors:  Hamad Ali; Naser Hussain; Medhat Naim; Mohamed Zayed; Fahd Al-Mulla; Elijah O Kehinde; Lauren M Seaburg; Jamie L Sundsbak; Peter C Harris
Journal:  BMC Nephrol       Date:  2015-03-01       Impact factor: 2.388

10.  Alterations of Proximal Tubular Secretion in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Ke Wang; Leila R Zelnick; Yan Chen; Andrew N Hoofnagle; Terry Watnick; Stephen Seliger; Bryan Kestenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-18       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.